INVO Fertility, Inc. (IVF)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Elimination of Intersegment Revenue	-27.00K	-29.00K	-
Fertility Clinic Services	6.72M	6.45M	2.86M
Fertility Clinic Services Growth	4.20%	125.34%	-
INVO Cell Device	147.19K	110.57K	158.00K
INVO Cell Device Growth	33.12%	-30.02%	-
Total	6.84M	6.53M	3.02M
Total Growth	4.73%	116.25%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
United States	6.84M	6.53M	3.02M
United States Growth	4.73%	116.25%	-
Total	6.84M	6.53M	3.02M
Total Growth	4.73%	116.25%	-

Data Source: S&P Global Market Intelligence Last updated: Jun 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 9, 2026

Data Sources Report a data error